CME/CE: Warfarin: Double-Edged Sword After PE
By: Alere Staff
American Heart Association
July 7, 2015 – July 7, 2017
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
After a first-time, unprovoked pulmonary embolism, an additional 18 months of warfarin, beyond the initial 6-month therapy, reduced the risk of a major event compared with placebo though the risk of major bleeding persisted, researchers found.